Nerandomilast 18 mg - adult formulation
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of British Columbia
Overview
Nerandomilast 18 mg - adult formulation is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Nerandomilast 18 mg - adult formulation clinical trials
Explore related
Medical disclaimer. This page summarizes research about Nerandomilast 18 mg - adult formulation for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.